UY35235A - Unidad sólida con alto contenido en fexofenadina y su procedimiento de preparación. - Google Patents

Unidad sólida con alto contenido en fexofenadina y su procedimiento de preparación.

Info

Publication number
UY35235A
UY35235A UY0001035235A UY35235A UY35235A UY 35235 A UY35235 A UY 35235A UY 0001035235 A UY0001035235 A UY 0001035235A UY 35235 A UY35235 A UY 35235A UY 35235 A UY35235 A UY 35235A
Authority
UY
Uruguay
Prior art keywords
fexofenadine
high content
solid unit
preparation procedure
solid
Prior art date
Application number
UY0001035235A
Other languages
English (en)
Inventor
Baptiste Merillon
Lanne Jean-Yves
Marie Renouard
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47902228&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UY35235(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of UY35235A publication Critical patent/UY35235A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente invención se refiere a composiciones farmacéuticas, destinadas a ser utilizadas en forma de unidad sólida tal como un comprimido, para una administración por vía oral, que comprenden un alto contenido en fexofenadina y/o en al menos una de sus sales farmacéuticamente aceptables, así como a los procedimientos de fabricación de unidades sólidas por vía ?hot melt?.
UY0001035235A 2012-12-21 2013-12-20 Unidad sólida con alto contenido en fexofenadina y su procedimiento de preparación. UY35235A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1262647A FR2999937B1 (fr) 2012-12-21 2012-12-21 Unite solide a haute teneur en fexofenadine et son procede de preparation

Publications (1)

Publication Number Publication Date
UY35235A true UY35235A (es) 2014-07-31

Family

ID=47902228

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001035235A UY35235A (es) 2012-12-21 2013-12-20 Unidad sólida con alto contenido en fexofenadina y su procedimiento de preparación.

Country Status (25)

Country Link
US (1) US9757340B2 (es)
EP (1) EP2934491B1 (es)
JP (1) JP6276287B2 (es)
KR (1) KR20150100725A (es)
CN (1) CN105073101B (es)
AR (1) AR094146A1 (es)
AU (1) AU2013366512B2 (es)
BR (1) BR112015014137B8 (es)
CA (1) CA2895607A1 (es)
CL (1) CL2015001681A1 (es)
EA (1) EA030982B1 (es)
ES (1) ES2625447T3 (es)
FR (1) FR2999937B1 (es)
HK (1) HK1211234A1 (es)
HU (1) HUE032393T2 (es)
IL (1) IL239267A0 (es)
MX (1) MX360047B (es)
PH (1) PH12015501377A1 (es)
PL (1) PL2934491T3 (es)
SG (1) SG11201504394TA (es)
TN (1) TN2015000267A1 (es)
TW (1) TWI624275B (es)
UY (1) UY35235A (es)
WO (1) WO2014096387A1 (es)
ZA (1) ZA201504079B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2900597C (en) 2013-02-14 2021-11-02 Sanofi Chewable composition for oral administration and process for preparing thereof
WO2017073738A1 (ja) * 2015-10-29 2017-05-04 日本臓器製薬株式会社 フェキソフェナジンを有効成分とする錠剤
KR20220123689A (ko) 2020-03-11 2022-09-08 사와이세이야쿠 가부시키가이샤 과립 및 그것을 이용한 제제
WO2023145871A1 (ja) * 2022-01-31 2023-08-03 住友精化株式会社 製剤用組成物の製造方法及び製剤の製造方法
WO2023145869A1 (ja) * 2022-01-31 2023-08-03 住友精化株式会社 製剤用組成物の製造方法及び製剤の製造方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK164642C (da) * 1984-08-30 1992-12-14 Merrell Dow Pharma Farmaceutisk middel indeholdende terfenadin i form af en varmsmelte paafyldt paa kapsler
CN1044319C (zh) * 1984-08-30 1999-07-28 默里尔多药物公司 热熔融抗组胺组合物的制备方法
EP0812195B1 (en) 1995-02-28 2002-10-30 Aventis Pharmaceuticals Inc. Pharmaceutical composition for piperidinoalkanol compounds
US6723348B2 (en) * 2001-11-16 2004-04-20 Ethypharm Orodispersible tablets containing fexofenadine
ATE381350T1 (de) * 2003-03-07 2008-01-15 Ind Swift Ltd Geschmacklose, direkt verpressbare, schnelllösliche komplexe und ihre pharmazeutischen zusammensetzungen.
FR2959130A1 (fr) * 2010-04-21 2011-10-28 Sanofi Aventis Procede de preparation de compositions pharmaceutiques destinees a l'administration par voie orale comprenant un ou plusieurs principes actifs et les compositions les comprenant.
CA2900597C (en) 2013-02-14 2021-11-02 Sanofi Chewable composition for oral administration and process for preparing thereof

Also Published As

Publication number Publication date
JP6276287B2 (ja) 2018-02-07
CA2895607A1 (en) 2014-06-26
JP2016511223A (ja) 2016-04-14
ZA201504079B (en) 2016-04-28
EP2934491A1 (en) 2015-10-28
US20150313885A1 (en) 2015-11-05
HK1211234A1 (en) 2016-05-20
EA030982B1 (ru) 2018-10-31
EA201591150A1 (ru) 2015-11-30
WO2014096387A1 (en) 2014-06-26
AR094146A1 (es) 2015-07-15
ES2625447T3 (es) 2017-07-19
MX360047B (es) 2018-10-19
FR2999937B1 (fr) 2015-01-09
FR2999937A1 (fr) 2014-06-27
TW201431569A (zh) 2014-08-16
TWI624275B (zh) 2018-05-21
CN105073101A (zh) 2015-11-18
KR20150100725A (ko) 2015-09-02
AU2013366512A1 (en) 2015-07-09
AU2013366512B2 (en) 2017-11-09
BR112015014137B1 (pt) 2022-12-13
BR112015014137A2 (pt) 2017-07-11
SG11201504394TA (en) 2015-07-30
CN105073101B (zh) 2018-10-09
CL2015001681A1 (es) 2015-08-21
EP2934491B1 (en) 2017-02-22
HUE032393T2 (en) 2017-09-28
PL2934491T3 (pl) 2017-09-29
IL239267A0 (en) 2015-07-30
MX2015008068A (es) 2016-04-25
TN2015000267A1 (en) 2016-10-03
PH12015501377A1 (en) 2015-09-02
BR112015014137B8 (pt) 2023-01-24
US9757340B2 (en) 2017-09-12

Similar Documents

Publication Publication Date Title
BR112015018838A2 (pt) estabilidade melhorada de novas composições líquidas
UA106636C2 (uk) Морфолінотіазоли як позитивні алостеричні модулятори альфа 7
CL2012002424A1 (es) Método para tratar artitris reumatoide que comprende administrar al paciente laquinimod y metotrexato por vía oral; composición farmacéutica que los comprende.
CO7190242A2 (es) Moduladores del transporte nuclear y usos de los mismos
BR112015000106A2 (pt) moduladores heterocíclicos de síntes de lipídio
CO6400186A2 (es) Tabletas de acetato de ulipristal
CO6491060A2 (es) Compuestos y composiciones para el tratamiento de enfermedades parasitarias
UY35235A (es) Unidad sólida con alto contenido en fexofenadina y su procedimiento de preparación.
DOP2012000050A (es) Nuevas composiciones de 1-[2-(2,4-dimetil-fenilsulfanil)-fenil] piperazina
BR112015017451A2 (pt) formulações farmacêuticas resistentes à violação
CR20110680A (es) Sulfonamidas heterociclicas, usos y composiciones farmacéuticas de las mismas
CL2014001828A1 (es) Sistema de dosificacion oral de liberacion dual que comprende doxilamina y piridoxina y/o sus analogos, metabolitos y sales de los mismos; forma de dosificacion oral de liberacion dual; kit farmaceutico; uso para aliviar los sintomas de nauseas y vomitos, incluidos los del embarazo.
GT201400059A (es) Derivados de estra-1,3,5(10),16-tetraen-3-carboxamida, proceidmientos para su preparación, preparados farmacéuticos que los contienen, así como su uso para la preparacion de medicamentos
ECSP13012667A (es) Compuestos de triazolopiridina
BRPI1007484A2 (pt) composição farmacêutica para administração oral
UY34166A (es) Composición farmacéutica oftalmológica tópica que contiene regorafenib
EA201200485A1 (ru) Перорально распадающаяся фармацевтическая лекарственная форма, содержащая арипипразол
MX2015010486A (es) Composicion masticable para administracion oral y proceso para preparar la misma.
UY34080A (es) Composición farmacéutica para administración oral que comprende fexofenadina y métodos de preparación
MX2014006574A (es) Formulaciones de acamprosato, metodos de uso de las mismas, y combinaciones que comprenden las mismas.
BR112013025610A2 (pt) uso de um metapneumovírus aviário vivo, e, composição farmacêutica
PL395069A1 (pl) Przeciwbólowa kompozycja farmaceutyczna do podawania doustnego
UY35329A (es) Composición farmacéutica para administración oral que comprende fexofenadina y proceso para preparar la misma.
EA201590732A1 (ru) Диспергируемая таблетка
CR20150411A (es) Composiciones farmacéuticas que contienen dexketoprofeno y tramadol

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20210715